Core Viewpoint - The company plans to acquire 100% equity of Guangzhou Yijie Medical Technology Co., Ltd. through a combination of issuing shares and cash payment, along with raising supporting funds, which constitutes a related party transaction [1] Group 1: Confidentiality Measures - The company has established an insider information management system to regulate insider information management as approved in the board meeting on August 11, 2022 [1] - The company has signed confidentiality agreements with the transaction counterparties to ensure strict confidentiality regarding the transaction details, disclosing information only as required by law or necessary for the transaction [1] - The company has implemented a registration management system for insider information personnel, limiting the knowledge scope of sensitive information related to the transaction [2] Group 2: Insider Information Management - The company has created an "Insider Information Personnel Registration Form" and a "Transaction Progress Memorandum," and has reported the list of insider information personnel to the Shenzhen Stock Exchange [2] - The company has conducted multiple reminders to insider information personnel about their confidentiality obligations and responsibilities, prohibiting them from disclosing information or trading based on insider information before legal disclosure [2] - The company has taken necessary and sufficient confidentiality measures, established a strict confidentiality system, and signed confidentiality clauses with transaction counterparties, ensuring compliance with confidentiality obligations prior to legal disclosure of the transaction information [2]
迈普医学: 关于本次交易采取的保密措施及保密制度的说明